Grant: Doctoral: Vanier Canada Graduate Scholarships
University of Toronto
$150,000.00
Molecular Targeting of Aurora Kinases in Glioblastoma Multiforme
FY 2010-11
Summary
There is no cure for brain cancer at the present time and our best therapies only prolong survival by a few months. The current treatment of brain cancer involves surgical removal of the tumor, chemotherapy, and radiation. We know that despite complete or almost complete tumor removal and subsequent standard chemotherapy and radiation, cancer cells continue to divide and invade producing new tumors at the surgical site or at other sites in the brain. Our study will shed light on the process that allows brain cancer cells to divide and grow. We are in the process of developing smart drugs that will hone in to brain cancer cells, blocking their growth and inducing cells to self-destruct. These novel therapies will be specific and overcome challenges of entry into the brain substance which limit current treatment. As such they will provide new options for the treatment of brain cancer patients. The ability to stop cancer cells from growing and to induce their self-destruction is expected to improve the quality of life and survival of patients with brain cancer.
Department
Program
Doctoral: Vanier Canada Graduate Scholarships
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
217991
Name
Diaz Roberto J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Biomedical
Prcname2
Vanier Canada Graduate Scholarships CIHR
Projecttitle
Molecular Targeting of Aurora Kinases in Glioblastoma Multiforme
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$150,000
Cihrequipment2
$0
Programname2
Doctoral: Vanier Canada Graduate Scholarships
Keyworddelim
Aurora Kinases; Brain Tumors; Cell Cycle Control; Chemotherapeutics; Nanotechnology; Translational Research
Abstract
There is no cure for brain cancer at the present time and our best therapies only prolong survival by a few months. The current treatment of brain cancer involves surgical removal of the tumor, chemotherapy, and radiation. We know that despite complete or almost complete tumor removal and subsequent standard chemotherapy and radiation, cancer cells continue to divide and invade producing new tumors at the surgical site or at other sites in the brain. Our study will shed light on the process that allows brain cancer cells to divide and grow. We are in the process of developing smart drugs that will hone in to brain cancer cells, blocking their growth and inducing cells to self-destruct. These novel therapies will be specific and overcome challenges of entry into the brain substance which limit current treatment. As such they will provide new options for the treatment of brain cancer patients. The ability to stop cancer cells from growing and to induce their self-destruction is expected to improve the quality of life and survival of patients with brain cancer.
Competitiondate
201010
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Diaz, Roberto J
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $150,000~ $0~